{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:23:47Z","timestamp":1783164227951,"version":"3.54.6"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002349","name":"Academy of Scientific Research and Technology","doi-asserted-by":"publisher","award":["NBU-FPEJ- 2024-337-03"],"award-info":[{"award-number":["NBU-FPEJ- 2024-337-03"]}],"id":[{"id":"10.13039\/501100002349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ijbiomac.2024.134535","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T19:38:47Z","timestamp":1722886727000},"page":"134535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"P4","title":["Comprehensive insight into exploring the potential of microbial enzymes in cancer therapy: Progress, challenges, and opportunities: A review"],"prefix":"10.1016","volume":"277","author":[{"given":"Fareed Shawky","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmail M.","family":"El-Fakharany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousra A.","family":"El-Maradny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed K.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Mazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Jame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Saleem","family":"Alatawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamada","family":"El-Gendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.134535_bb0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022, CA","volume":"72","author":"Miller","year":"2022","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0010","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0015","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/biom11030392","article-title":"Potential role of curcumin and its nanoformulations to treat various types of cancers","volume":"11","author":"Kabir","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/02813432.2015.1067512","article-title":"Symptoms, signs, and tests: the general practitioner\u2019s comprehensive approach towards a cancer diagnosis","volume":"33","author":"Scheel","year":"2015","journal-title":"Scand. J. Prim. Health Care"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1634\/theoncologist.2019-0289","article-title":"Impact of baseline nutrition and exercise status on toxicity and outcomes in phase I and II oncology clinical trial participants","volume":"25","author":"Jain","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0030","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.adro.2020.05.008","article-title":"Nutrition in cancer: evidence and equality","volume":"5","author":"Haskins","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0035","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.biopha.2007.10.006","article-title":"Lifestyle-related factors and environmental agents causing cancer: an overview","volume":"61","author":"Irigaray","year":"2007","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0040","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.3390\/cancers13112625","article-title":"Virus-driven carcinogenesis","volume":"13","author":"Hatano","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1470-2045(19)30595-9","article-title":"Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study","volume":"21","author":"Koo","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0050","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","author":"Anand","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/anie.201307628","article-title":"Antibody-drug conjugates: an emerging concept in cancer therapy","author":"Chari","year":"2014","journal-title":"Angew. Chemie-Int. Ed."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130997","article-title":"A review on L-methioninase in cancer therapy: precision targeting, advancements and diverse applications for a promising future","volume":"265","author":"Javia","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103940","article-title":"Treating liver cancer through arginine depletion","volume":"29","author":"Prasad","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0070","article-title":"Alone and together: current approaches to targeting glutaminase enzymes as part of anti-cancer therapies","volume":"4","author":"Nguyen","year":"2023","journal-title":"Futur. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s13577-022-00821-2","article-title":"The exploitation of enzyme-based cancer immunotherapy","volume":"36","author":"Chandan","year":"2023","journal-title":"Hum. Cell"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0080","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4155\/tde-2017-0020","article-title":"Targeting and delivery of therapeutic enzymes","volume":"8","author":"Dean","year":"2017","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.crbiot.2021.05.006","article-title":"Microbial therapeutic enzymes: a promising area of biopharmaceuticals","author":"Vachher","year":"2021","journal-title":"Curr. Res. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0090","series-title":"Bioresour. Bioprocess Biotechnol. Vol. 2 Explor. Potential Biomol","first-page":"45","article-title":"Therapeutic enzymes","author":"Kumar","year":"2017"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.plaphy.2011.12.004","article-title":"Purification and physicochemical characterization of a serine protease with fibrinolytic activity from latex of a medicinal herb Euphorbia hirta","volume":"52","author":"Patel","year":"2012","journal-title":"Plant Physiol. Biochem."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0100","article-title":"Enzymes as drugs: an overview","volume":"3","author":"Kaur","year":"2012","journal-title":"J. Pharm. Educ. Res."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1207\/S15327914NC330201","article-title":"Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification support","volume":"33","author":"Gonzalez","year":"1999","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0110","article-title":"Therapeutic enzymes: discoveries, production and applications","volume":"63","author":"Tandon","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0115","article-title":"Recent trends in targeted delivery of smart nanocarrier-based microbial enzymes for therapeutic applications","volume":"103915","author":"Jangra","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijbiomac.2021.12.015","article-title":"Microbial arginine deiminase: a multifaceted green catalyst in biomedical sciences","volume":"196","author":"Kawatra","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0125","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ijbiomac.2018.05.030","article-title":"Purification and characterization of a new thermophilic collagenase from Nocardiopsis dassonvillei NRC2aza and its application in wound healing","volume":"116","author":"Abood","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2023.109800","article-title":"Highly selective fluorometric detection of streptokinase via fibrinolytic release of photoluminescent carbon dots integrated into fibrin clot network","volume":"197","author":"Alanazi","year":"2024","journal-title":"Microchem. J."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0135","series-title":"Bioresources and Bioprocess in Biotechnology: Volume 2: Exploring Potential Biomolecules","author":"Sugathan","year":"2017"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0140","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/nbt1007-1097","article-title":"What\u2019s fueling the biotech engine?","volume":"25","author":"Aggarwal","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0145","series-title":"Adv. Enzym. Technol","first-page":"1","article-title":"Microbial enzymes\u2014an overview","author":"Singh","year":"2019"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2023.103870","article-title":"Isolation and characterization of Trichoderma harzianum L-methioninase with promising a powerful anticancer","volume":"30","author":"Ashkan","year":"2023","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12934-023-02019-z","article-title":"Purification, characterization and anticancer activity of L-methionine \u03b3-lyase from thermo-tolerant Aspergillus fumigatus","volume":"22","author":"Hendy","year":"2023","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0160","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2174\/1389201018666170808150742","article-title":"Therapeutic enzymes: applications and approaches to pharmacological improvement","volume":"18","author":"Yari","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/cben.201600002","article-title":"Production and purification of recombinant proteins from Escherichia coli","volume":"3","author":"Tripathi","year":"2016","journal-title":"ChemBioEng Rev."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00419","article-title":"Sophisticated cloning, fermentation, and purification technologies for an enhanced therapeutic protein production: a review","author":"Gupta","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0175","doi-asserted-by":"crossref","DOI":"10.1080\/07388550601173926","article-title":"L-asparaginase: a promising chemotherapeutic agent","author":"Verma","year":"2007","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/jof10050323","article-title":"Synthesis of extracellular L-lysine-\u03b1-oxidase along with degrading enzymes by Trichoderma cf. aureoviride Rifai VKM F-4268D: role in biocontrol and systemic plant resistance","volume":"10","author":"Arinbasarova","year":"2024","journal-title":"J. Fungi"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0185","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/ph14111070","article-title":"L-lysine \u03b1-oxidase: enzyme with anticancer properties","volume":"14","author":"Lukasheva","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0190","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12934-024-02469-z","article-title":"Purification and characterization of the produced hyaluronidase by Brucella intermedia MEFS for antioxidant and anticancer applications","volume":"23","author":"Ebraheem","year":"2024","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/15422119.2016.1184167","article-title":"L-asparaginase purification","volume":"46","author":"Tundisi","year":"2017","journal-title":"Sep. Purif. Rev."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201600105","article-title":"Cellular engineering for therapeutic protein production: product quality, host modification, and process improvement","volume":"12","author":"Wells","year":"2017","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0205","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jbiotec.2017.04.028","article-title":"Therapeutic glycoprotein production in mammalian cells","volume":"251","author":"Lalonde","year":"2017","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0210","first-page":"40","article-title":"Recombinant protein therapeutics from CHO cells-20 years and counting","volume":"103","author":"Jayapal","year":"2007","journal-title":"Chem. Eng. Prog."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0215","first-page":"5767","article-title":"Pivotal trial with plant cell\u2013expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease, Blood","volume":"118","author":"Zimran","year":"2011","journal-title":"J. Am. Soc. Hematol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0220","series-title":"Handb. Ind. Chem. Biotechnol","article-title":"Industrial production of therapeutic proteins: cell lines, cell culture, and purification","author":"Zhu","year":"2017"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0225","doi-asserted-by":"crossref","DOI":"10.3906\/biy-1411-8","article-title":"Development of therapeutic proteins: advances and challenges","author":"Akash","year":"2015","journal-title":"Turkish J. Biol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.717326","article-title":"Purification of modified therapeutic proteins available on the market: an analysis of chromatography-based strategies","author":"S\u00e1nchez-Trasvi\u00f1a","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0235","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.98.6.565","article-title":"Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum: I. course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum","volume":"98","author":"Kidd","year":"1953","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0240","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/1911114a0","article-title":"Evidence that the L-asparaginase activity of guinea pig serum is responsible for its antilymphoma effects","volume":"191","author":"Broome","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0245","first-page":"967","article-title":"Antilymphoma activity of L-asparaginase in vivo: clearance rates of enzyme preparations from guinea pig serum and yeast in relation to their effect on tumor growth","volume":"35","author":"Broome","year":"1965","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0250","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0003-9861(54)90174-5","article-title":"Stereospecific asparaginases in smooth Brucella abortus, strain 19","volume":"49","author":"Altenbern","year":"1954","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0255","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1021\/bi00855a011","article-title":"Two L-asparaginases from Escherichia coli B. Their separation, purification, and antitumor activity","volume":"6","author":"Campbell","year":"1967","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0260","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jbiotec.2006.07.037","article-title":"L-Asparaginase from Erwinia chrysanthemi 3937: cloning, expression and characterization","volume":"127","author":"Kotzia","year":"2007","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0265","first-page":"75","article-title":"Structure, substrate complexation and reaction mechanism of bacterial asparaginases","volume":"1","author":"Sanches","year":"2007","journal-title":"Curr. Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0270","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3109\/10428194.2014.1003056","article-title":"Asparaginase pharmacokinetics and implications of therapeutic drug monitoring","volume":"56","author":"Asselin","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0275","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00280-021-04315-0","article-title":"Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase","volume":"88","author":"Panetta","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.902117","article-title":"Current use of asparaginase in acute lymphoblastic leukemia\/lymphoblastic lymphoma","volume":"10","author":"Maese","year":"2022","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0285","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/diagnostics14060623","article-title":"Determination of L-asparaginase activity and its therapeutic monitoring in children with hematological malignancies in a single croatian center","volume":"14","author":"Lenicek Krleza","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0290","doi-asserted-by":"crossref","first-page":"179","DOI":"10.15414\/jmbfs.2019.9.2.179-190","article-title":"L-asparaginase and l-glutaminase: sources, production, and applications in medicine and industry","volume":"9","author":"Orabi","year":"2019","journal-title":"J. Microbiol. Biotechnol. Food Sci."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0295","first-page":"813","article-title":"Persian gulf is a bioresource of potent L-asparaginase producing bacteria: isolation & molecular differentiating","volume":"8","author":"Izadpanah Qeshmi","year":"2014","journal-title":"Int. J. Environ. Res."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0300","first-page":"1","article-title":"Purification and biotechnological applications of L-asparaginase from newly isolated Bacillus halotolerans OHEM18 as antitumor and antioxidant agent","volume":"0","author":"El-Fakharany","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0305","first-page":"465","article-title":"Studies on L-asparaginase enzyme of actinomycetes isolated from estuarine fishes","volume":"28","author":"Sahu","year":"2007","journal-title":"J. Environ. Biol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0310","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/10826068.2012.672943","article-title":"Kinetic studies of L-asparaginase from Penicillium digitatum","volume":"42","author":"Shrivastava","year":"2012","journal-title":"Prep. Biochem. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0315","article-title":"A comprehensive insight into fungal enzymes: structure, classification, and their role in mankind\u2019s challenges","author":"El-Gendi","year":"2022","journal-title":"J. Fungi."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0320","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.biortech.2017.05.059","article-title":"Recent developments in l-glutaminase production and applications \u2013 an overview","volume":"245","author":"Binod","year":"2017","journal-title":"Bioresour. Technol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/S0032-9592(03)00035-9","article-title":"Continuous production of L-glutaminase by an immobilized marine Pseudomonas sp BTMS-51 in a packed bed reactor","author":"Kumar","year":"2003","journal-title":"Process Biochem."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0330","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1007\/s00253-021-11416-6","article-title":"Bio-prospecting the future in perspective of amidohydrolase L-glutaminase from marine habitats","volume":"105","author":"Patel","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0335","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1471-4159.2003.02146.x","article-title":"Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: linkage to HIV-1 associated dementia","volume":"88","author":"Zhao","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0340","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.ijbiomac.2019.10.131","article-title":"Purification and characterization of L-glutaminase enzyme from camel liver: enzymatic anticancer property","volume":"150","author":"Maharem","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0345","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s42269-021-00693-w","article-title":"Production, characterization, and antitumor efficiency of l-glutaminase from halophilic bacteria","volume":"46","author":"Gomaa","year":"2022","journal-title":"Bull. Natl. Res. Cent."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0350","series-title":"Purification, Kinetic Properties and Antitumor Activity of L-glutaminase from Penicillium Brevicompactum NRC 829","author":"Elshafei","year":"2014"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0355","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2020.12.038","article-title":"Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models","volume":"502","author":"Wicker","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0360","first-page":"337","article-title":"L-amino acid oxidases: properties and molecular mechanisms of action","volume":"5","author":"Lukasheva","year":"2011","journal-title":"Biochem. Suppl. Ser. B Biomed. Chem."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbrep.2016.11.003","article-title":"Kinetic characteristics of L-lysine \u03b1-oxidase from Trichoderma cf. aureoviride Rifai VKM F-4268D: substrate specificity and allosteric effects","volume":"9","author":"Krupyanko","year":"2017","journal-title":"Biochem. Biophys. Reports."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0370","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/CAD.0b013e328362fbe2","article-title":"Enzymatic properties and anticancer activity of L-lysine \u03b1-oxidase from Trichoderma cf. aureoviride Rifai BKMF-4268D","volume":"24","author":"Pokrovsky","year":"2013","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0375","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3389\/fmicb.2020.00977","article-title":"L-amino acid oxidases from mushrooms show antibacterial activity against the phytopathogen Ralstonia solanacearum","volume":"11","author":"Saboti\u010d","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0380","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1007\/s00253-021-11381-0","article-title":"Antimicrobial properties of L-amino acid oxidase: biochemical features and biomedical applications","volume":"105","author":"Kasai","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0385","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10549-020-05801-4","article-title":"Lysine oxidase exposes a dependency on the thioredoxin antioxidant pathway in triple-negative breast cancer cells","volume":"183","author":"Chepikova","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0390","series-title":"Semin. Cancer Biol","first-page":"590","article-title":"Cytotoxic activity of l-lysine alpha-oxidase against leukemia cells","author":"Costa","year":"2022"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0395","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12934-024-02315-2","article-title":"The recombinant l-lysine \u03b1-oxidase from the fungus Trichoderma harzianum promotes apoptosis and necrosis of leukemia CD34+ hematopoietic cells","volume":"23","author":"Costa","year":"2024","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0400","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbamem.2014.01.027","article-title":"Regulation of the cancer cell membrane lipid composition by NaCHOleate: effects on cell signaling and therapeutical relevance in glioma","volume":"1838","author":"Llad\u00f3","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembranes."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0405","first-page":"130","article-title":"The effect of L-lysine alpha-oxidase from Trichoderma cf. aureoviride Rifai VKM F-4268D on the rat pheochromocytoma PC12 cell line","volume":"8","author":"Lukasheva","year":"2014","journal-title":"Biochem. Suppl. Ser. B Biomed. Chem."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0410","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1006906505745","article-title":"Identification of L-amino acid\/L-lysine \u03b1-amino oxidase in mouse brain","volume":"197","author":"Murthy","year":"1999","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0415","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0041-0101(02)00102-2","article-title":"Snake venom L-amino acid oxidases","volume":"40","author":"Du","year":"2002","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0420","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF02976576","article-title":"Cytotoxicity and L-amino acid oxidase activity of crude insect drugs","volume":"23","author":"Ahn","year":"2000","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0425","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cbpb.2009.05.006","article-title":"Isolation and cDNA cloning of an antibacterial L-amino acid oxidase from the skin mucus of the great sculpin Myoxocephalus polyacanthocephalus","volume":"154","author":"Nagashima","year":"2009","journal-title":"Comp. Biochem. Physiol. Part B Biochem. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0430","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1007\/s00253-014-6308-0","article-title":"Functional expression of L-lysine \u03b1-oxidase from Scomber japonicus in Escherichia coli for one-pot synthesis of L-pipecolic acid from DL-lysine","volume":"99","author":"Tani","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0435","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1002\/pro.3946","article-title":"Structural basis of strict substrate recognition of l-lysine \u03b1-oxidase from Trichoderma viride","volume":"29","author":"Kondo","year":"2020","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0440","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.bbapap.2006.08.014","article-title":"A novel type of lysine oxidase: L-lysine-\u03b5-oxidase","volume":"1764","author":"G\u00f3mez","year":"2006","journal-title":"Biochim. Biophys. Acta (BBA)-Proteins Proteomics."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0445","doi-asserted-by":"crossref","first-page":"27283","DOI":"10.1007\/s11356-021-17925-1","article-title":"Plant asparaginase versus microbial asparaginase as anticancer agent","volume":"29","author":"Al-Hazmi","year":"2022","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1122010","article-title":"Clinical impacts of the concomitant use of L-asparaginase and total parenteral nutrition containing L-aspartic acid in patients with acute lymphoblastic leukemia","volume":"10","author":"Ko","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13568-024-01700-9","article-title":"Production of highly cytotoxic and low immunogenic L-asparaginase from Stenotrophomonas maltophilia EMCC2297","volume":"14","author":"Abdelrazek","year":"2024","journal-title":"AMB Express"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0460","first-page":"1146","article-title":"L-asparaginase produced from soil isolates of Pseudomonas aeruginosa shows potent anti-cancer activity on HeLa cells, Saudi","volume":"26","author":"Fatima","year":"2019","journal-title":"Aust. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0465","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1038\/s41598-019-40512-x","article-title":"Production and anticancer activity of an L-asparaginase from Bacillus licheniformis isolated from the Red Sea, Saudi Arabia","volume":"9","author":"Alrumman","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0470","article-title":"Enhanced anti-cancer potency of sustainably synthesized anisotropic silver nanoparticles as compared with L-asparaginase","volume":"130238","author":"Naqvi","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0475","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00280-017-3492-5","article-title":"Pharmacokinetics of recombinant asparaginase in children with acute lymphoblastic leukemia","volume":"81","author":"V\u00f6ller","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0288620","article-title":"Characterization and applications of glutaminase free L-asparaginase from indigenous Bacillus halotolerans ASN9","volume":"18","author":"Shafqat","year":"2023","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0485","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29169","article-title":"Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?","volume":"68","author":"Maese","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0490","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/fcp.12257","article-title":"Growth inhibitory and proapoptotic effects of l-asparaginase from Fusarium culmorum ASP-87 on human leukemia cells (Jurkat)","volume":"31","author":"Meghavarnam","year":"2017","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0495","first-page":"132","article-title":"Purification, characterization and kinetic properties of Penicillium cyclopium L-asparaginase: impact of L-asparaginase on acrylamide content in potato products and its cytotoxic activity","volume":"9","author":"Shafei","year":"2015","journal-title":"Curr. Trends Biotechnol. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10856-015-5380-z","article-title":"Anticancer activity of fungal l-asparaginase conjugated with zinc oxide nanoparticles","volume":"26","author":"Baskar","year":"2015","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0505","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/10826068.2022.2122064","article-title":"Bioprocessing and purification of extracellular L-asparaginase produced by endophytic Colletotrichum gloeosporioides and its anticancer activity","volume":"53","author":"Yap","year":"2023","journal-title":"Prep. Biochem. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0510","first-page":"2540","article-title":"Production, purification, characterization, antioxidant and antiproliferative activities of extracellular L-asparaginase produced by Fusarium equiseti AHMF4, Saudi","volume":"28","author":"El-Gendy","year":"2021","journal-title":"Aust. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0515","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.22207\/JPAM.12.4.19","article-title":"Purification, characterization and anticancer activity of L-asparaginase produced by marine Aspergillus terreus","volume":"12","author":"Hassan","year":"2018","journal-title":"J Pure Appl Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0520","article-title":"Unveiling the anticancer potential of L-Asparaginase (ASNase) from novel Streptomyces isolate HB2AG: purification and characterization study","volume":"100076","author":"Rath","year":"2024","journal-title":"The Microbe."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0525","first-page":"23","article-title":"Production, purification, characterization and anti-leukemic activity of L-Asparaginase from Streptomyces Spp Aia 1 section: microbial and enzyme technology, Korean","volume":"28","author":"C.","year":"2024","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0530","first-page":"1","article-title":"Anticancer activity of L-asparaginase produced from Amycolatopsis japonica","author":"Salami","year":"2022","journal-title":"Int. J. Med. Phar. Drug Re."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0535","first-page":"9","article-title":"Manufacture of L-Asparaginase by Actinobacteria isolated from rhizosphere of plants in Tehran with strong anti-cancer activity","volume":"53","author":"Davarpanah","year":"2022","journal-title":"Egypt. J. Vet. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0540","article-title":"Optimization and purification of anticancer enzyme L-glutaminase from Alcaligenes faecalis KLU102","author":"Pandian","year":"2014","journal-title":"Biol"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0545","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/10826068.2019.1703193","article-title":"Production, optimization, purification, characterization, and anti-cancer application of extracellular L-glutaminase produced from the marine bacterial isolate","volume":"50","author":"Orabi","year":"2020","journal-title":"Prep. Biochem. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0550","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0555","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s12010-013-0371-3","article-title":"Biochemical characterization and antitumor study of L-glutaminase from Bacillus cereus MTCC 1305","volume":"171","author":"Singh","year":"2013","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0560","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5897\/AJMR2017.8630","article-title":"Purification and characterisation of a novel broad spectrum anti-tumor L-glutaminase enzyme from marine Bacillus subtilis strain JK-79","volume":"13","author":"Kiruthika","year":"2019","journal-title":"African J. Microbiol. Res."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0565","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3390\/molecules26071963","article-title":"L-glutaminase synthesis by marine Halomonas meridiana isolated from the red sea and its efficiency against colorectal cancer cell lines","volume":"26","author":"Mostafa","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0570","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10123-020-00156-8","article-title":"Purification, characterization, and anticancer and antioxidant activities of l-glutaminase from Aspergillus versicolor Faesay4","volume":"24","author":"Awad","year":"2021","journal-title":"Int. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0575","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2323\/jgam.2019.01.002","article-title":"Purification, characterization and anticancer efficiency of L-glutaminase from Aspergillus flavus","volume":"65","author":"Abu-Tahon","year":"2019","journal-title":"J. Gen. Appl. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0580","first-page":"957","article-title":"Kinetic properties of Streptomyces canarius L-Glutaminase and its anticancer efficiency, Brazilian","volume":"46","author":"Reda","year":"2015","journal-title":"J. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0585","article-title":"Anticancer property of L-glutaminase producing Actinomycete Streptomyces Albogriseolus isolated from estuary of Uttara Kannada District against Hela and HepG2 cell lines","volume":"45","author":"Mesta","year":"2024","journal-title":"J. Adv. Zool."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.134535_bb0590","article-title":"Production of the antitumor L-glutaminase enzyme from thermotolerant Streptomyces sp. D214, under submerged fermentation conditions","volume":"5","author":"Aly","year":"2017","journal-title":"J. Exp. Biol. Agric. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0595","first-page":"210","article-title":"The glutaminase inhibitor compound 968 exhibits potent in vitro and in vivo anti-tumor effects in endometrial cancer, anticancer","volume":"23","author":"Guo","year":"2022","journal-title":"Agents Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcab.2023.102621","article-title":"Enhanced l-Methioninase production by Methylobacterium sp. JUBTK33 through RSM and its anticancer potential","volume":"47","author":"Kavya","year":"2023","journal-title":"Biocatal. Agric. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0605","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s43094-023-00545-6","article-title":"Effect of physicochemical parameters on the L-methioninase activity of Methylobacterium sp. and its in vitro anticancer activity in combination with tamoxifen citrate","volume":"9","author":"Dayanand","year":"2023","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0610","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-4939-8796-2_17","article-title":"Pilot phase I clinical trial of methioninase on high-stage cancer patients: rapid depletion of circulating methionine, in","author":"Hoffman","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0615","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s13205-020-02494-w","article-title":"Purification, characterization and anticancer evaluation of l-methioninase from Trichoderma harzianum","volume":"10","author":"Salim","year":"2020","journal-title":"3 Biotech."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0620","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.molcatb.2016.11.002","article-title":"Aspergillus flavipes methionine \u03b3-lyase-dextran conjugates with enhanced structural, proteolytic stability and anticancer efficiency","volume":"133","author":"El-Sayed","year":"2016","journal-title":"J. Mol. Catal. B: Enzym."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0625","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.enzmictec.2012.06.004","article-title":"Pharmacokinetics, immunogenicity and anticancer efficiency of Aspergillus flavipes L-methioninase","volume":"51","author":"El-Sayed","year":"2012","journal-title":"Enzyme Microb. Technol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0630","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/173140","article-title":"Purification, characterization of L-methioninase from Candida tropicalis, and its application as an anticancer","volume":"2015","author":"Selim","year":"2015","journal-title":"Biotechnol. Res. Int."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0635","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7324\/JAPS.2016.60708","article-title":"Purification and characterization of a novel thermo stable L-methioninase from Streptomyces sp. DMMMH4 and its evaluation for anticancer activity","volume":"6","author":"Selim","year":"2016","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0640","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pep.2015.09.011","article-title":"Purification of a dimeric arginine deiminase from Enterococcus faecium GR7 and study of its anti-cancerous activity","volume":"125","author":"Kaur","year":"2016","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0645","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12896-024-00829-6","article-title":"Characterization, modeling, and anticancer activity of L. arginase production from marine Bacillus licheniformis OF2","volume":"24","author":"Selim","year":"2024","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0650","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cbi.2017.07.001","article-title":"Arginase purified from endophytic Pseudomonas aeruginosa IH2: induce apoptosis through both cell cycle arrest and MMP loss in human leukemic HL-60 cells","volume":"274","author":"Husain","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0655","doi-asserted-by":"crossref","first-page":"931","DOI":"10.21608\/asmj.2022.285473","article-title":"Screening and production of microbial L-arginase enzyme as anticancer agent from different soil environments in Egypt","volume":"73","author":"Kassab","year":"2022","journal-title":"Ain Shams Med. J."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0660","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s10637-021-01149-8","article-title":"Safety, PK\/PD and preliminary anti-tumor activities of pegylated recombinant human arginase 1 (BCT-100) in patients with advanced arginine auxotrophic tumors","volume":"39","author":"Cheng","year":"2021","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0665","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s10637-021-01111-8","article-title":"A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma","volume":"39","author":"Chan","year":"2021","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0670","doi-asserted-by":"crossref","DOI":"10.1007\/s12272-014-0498-y","article-title":"Purification and immobilization of l-arginase from thermotolerant Penicillium chrysogenum KJ185377.1; with unique kinetic properties as thermostable anticancer enzyme","author":"El-Sayed","year":"2014","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0675","first-page":"841","article-title":"Applicability of native L-arginase produced by streptomyces plicatus KAR73 as antineoplastic agent","volume":"80","author":"Gumashta","year":"2021","journal-title":"J. Sci. Ind. Res. (India)."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0680","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ijbiomac.2022.10.152","article-title":"L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: purification, characterization, G1 phase arrest and autophagy induction","volume":"224","author":"Hassabo","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0685","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s13205-023-03590-3","article-title":"Human arginase I: a potential broad-spectrum anti-cancer agent","volume":"13","author":"Anakha","year":"2023","journal-title":"3 Biotech."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0690","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12866-024-03192-w","article-title":"Purification and characterization of L-arginine deiminase from Penicillium chrysogenum","volume":"24","author":"El-Shora","year":"2024","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108924","article-title":"Streptococcus pyogenes upregulates arginine catabolism to exert its pathogenesis on the skin surface","volume":"34","author":"Hirose","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0700","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/bab.2375","article-title":"Characterization of a recombinant arginine deiminase from Halothermothrix orenii and its application in citrulline production","volume":"70","author":"Wang","year":"2023","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0705","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/1535-7163.MCT-09-0794","article-title":"Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc\/HIF-1\u03b1\/Sp4","volume":"8","author":"Tsai","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0710","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1021\/cb900267j","article-title":"Replacing Mn2+ with Co2+ in human arginase I enhances cytotoxicity toward L-arginine auxotrophic cancer cell lines","volume":"5","author":"Stone","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0715","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10600","article-title":"PEGylated therapeutics in the clinic","volume":"9","author":"Gao","year":"2024","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0720","article-title":"EL-Shawadfy, biochemical, molecular and anti-tumor characterization of L-methionine gamma lyase produced by local Pseudomonas sp. in Egypt, Saudi","volume":"30","author":"Abou Zeid","year":"2023","journal-title":"Aust. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.jece.2020.103870","article-title":"Immobilization of L-methionine \u03b3-lyase on different cellulosic materials and its potential application in green-selective synthesis of volatile sulfur compounds","volume":"8","author":"Abdelraof","year":"2020","journal-title":"J. Environ. Chem. Eng."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0730","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3390\/nu16070997","article-title":"Rescue of methionine dependence by cobalamin in a human colorectal cancer cell line","volume":"16","author":"Garg","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0735","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/506287","article-title":"L-methionase: a therapeutic enzyme to treat malignancies","volume":"2014","author":"Sharma","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0740","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0006-291X(83)91218-4","article-title":"The metabolic defect of methionine dependence occurs frequently in human tumor cell lines","volume":"117","author":"Mecham","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0745","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijbiomac.2021.03.201","article-title":"Conjugates of methionine \u03b3-lyase with polysialic acid: two approaches to antitumor therapy","volume":"182","author":"Morozova","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0750","doi-asserted-by":"crossref","first-page":"9181","DOI":"10.3390\/ijms22179181","article-title":"Enzyme therapy: current challenges and future perspectives","volume":"22","author":"de la Fuente","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0755","first-page":"3156","article-title":"Cyclosporine delays host immune response to antibody enzyme conjugate in ADEPT, in","author":"Bagshawe","year":"1996","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0760","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/87559129.2019.1695835","article-title":"Enzyme engineering: current trends and future perspectives","volume":"37","author":"Sharma","year":"2021","journal-title":"Food Rev. Int."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132254","article-title":"The use of proteins and peptides-based therapy in managing and preventing pathogenic viruses","volume":"270","author":"El-Fakharany","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0770","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40259-023-00622-5","article-title":"Enzyme engineering strategies for the bioenhancement of L-Asparaginase used as a biopharmaceutical","volume":"37","author":"Miranda","year":"2023","journal-title":"BioDrugs"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0775","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0958-1669(03)00092-2","article-title":"The enzyme as drug: application of enzymes as pharmaceuticals","volume":"14","author":"Vellard","year":"2003","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0780","article-title":"Research progress on the PEGylation of therapeutic proteins and peptides (TPPs)","volume":"15","author":"Li","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0785","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fbioe.2018.00212","article-title":"Development of L-asparaginase biobetters: current research status and review of the desirable quality profiles","volume":"6","author":"Brumano","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2023.130499","article-title":"Towards development of biobetter: L-asparaginase a case study","volume":"1868","author":"Tripathy","year":"2024","journal-title":"Biochim. Biophys. Acta-Gen. Subj."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0795","first-page":"242","article-title":"Obstacles and pitfalls in the PEGylation of therapeutic proteins","volume":"11","author":"Gaberc-Porekar","year":"2008","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0800","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157193","article-title":"XTEN as biological alternative to PEGylation allows complete expression of a protease-activatable killin-based cytostatic","volume":"11","author":"Haeckel","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0805","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2017.09.009","article-title":"Antibody directed enzyme prodrug therapy (ADEPT): trials and tribulations","volume":"118","author":"Sharma","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0810","first-page":"11","article-title":"Arginine deprivation therapy for malignant melanoma","author":"Yoon","year":"2012","journal-title":"Clin. Pharmacol. Adv. Appl."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107627","article-title":"Treatment and outcomes of symptomatic hyperammonemia following asparaginase therapy in children with acute lymphoblastic leukemia","volume":"139","author":"Lee","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0820","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bcab.2017.09.009","article-title":"An extensive review on L-methioninase and its potential applications","volume":"12","author":"Suganya","year":"2017","journal-title":"Biocatal. Agric. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0825","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bcp.2015.09.013","article-title":"Identification of novel nitroreductases from Bacillus cereus and their interaction with the CB1954 prodrug","volume":"98","author":"Gwenin","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0830","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/bjc.1987.237","article-title":"Antibody directed enzymes revive anti-cancer prodrugs concept","volume":"56","author":"Bagshawe","year":"1987","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0835","article-title":"DAMPAned methotrexate: a case report and review of the management of acute methotrexate toxicity","volume":"6","author":"Young","year":"2019","journal-title":"Can. J. Kidney Heal. Dis."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0840","article-title":"Valsartan mitigates the progression of methotrexate-induced acute kidney injury in rats via the attenuation of renal inflammation and oxidative stress","volume":"2233\u20132243","author":"Kutbi","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0845","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/17425255.2023.2272593","article-title":"The use of glucarpidase as a rescue therapy for high dose methotrexate toxicity\u2013a review of pharmacological and clinical data","volume":"19","author":"Kielbowski","year":"2023","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0850","article-title":"Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy","volume":"1\u201313","author":"Ogawa","year":"2024","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115292","article-title":"Glucarpidase (carboxypeptidase G2): biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy","volume":"166","author":"Moradbeygi","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0860","article-title":"Development of ZD2767P\u2013carboxypeptidase G2\u2013ultrasound therapy against cisplatin-resistant cancer","volume":"13","author":"Yu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0865","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/molecules26030625","article-title":"Coupling of a novel timp3 peptide to carboxypeptidase g2 for pro-drug activation at the tumour site","volume":"26","author":"Aldughaim","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0870","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/17425247.2016.1232248","article-title":"Pharmacokinetic profiles of cancer sonochemotherapy","volume":"14","author":"Zhang","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0875","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1021\/acs.molpharmaceut.0c00008","article-title":"Ultrasound enhances ZD2767P\u2013carboxypeptidase G2 against chemoresistant ovarian cancer cells by altering the intracellular pharmacokinetics of ZD2767D","volume":"17","author":"Liu","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0880","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications","volume":"200","author":"Wicki","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0885","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nantod.2019.02.005","article-title":"Clinical cancer nanomedicine","volume":"25","author":"Wolfram","year":"2019","journal-title":"Nano Today."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130960","article-title":"Application and progress of nanozymes in antitumor therapy","volume":"265","author":"He","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0895","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13770-022-00430-y","article-title":"Nanozyme-based enhanced cancer immunotherapy","volume":"19","author":"Phan","year":"2022","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102059","article-title":"A cascaded enzyme system based on the catalase-like activity of Ti3C2Tx MXene nanosheets for the efficient combination cancer therapy","volume":"54","author":"Qiao","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0905","article-title":"Nano iron doped calcium phosphates act as pH-sensitive and biodegradable peroxidase-like nanozymes for cancer chemodynamic therapy and MRI contrast","volume":"35","author":"Ribeiro","year":"2024","journal-title":"Mater. Today Chem."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0910","article-title":"L-Asparaginase delivery systems targeted to minimize its side-effects","volume":"102915","author":"Talluri","year":"2023","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0915","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/pharmaceutics15051537","article-title":"Cinchonain Ia shows promising antitumor effects in combination with L-asparaginase-loaded nanoliposomes","volume":"15","author":"Nguyen","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0920","doi-asserted-by":"crossref","DOI":"10.1002\/star.202100152","article-title":"Fabrication of oleic acid grafted starch-based hybrid carriers for l-Asparaginase encapsulation","volume":"76","author":"Haf\u0131zosmano\u011flu","year":"2024","journal-title":"Starch-St\u00e4rke"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0925","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1182\/blood.V118.21.4252.4252","article-title":"L-asparaginase loaded red blood cells: from prescription to injection","volume":"118","author":"Bailly","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0930","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12951-024-02326-6","article-title":"Selective enhanced cytotoxicity of amino acid deprivation for cancer therapy using thermozyme functionalized nanocatalyst","volume":"22","author":"Tang","year":"2024","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0935","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1074\/jbc.TM118.004156","article-title":"Proteases: history, discovery, and roles in health and disease","volume":"294","author":"Bond","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0940","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1002\/cctc.202001107","article-title":"Looking Back: a short history of the discovery of enzymes and how they became powerful chemical tools","volume":"12","author":"Heckmann","year":"2020","journal-title":"ChemCatChem"},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0945","doi-asserted-by":"crossref","DOI":"10.1007\/s13205-021-02962-x","article-title":"Management of microbial enzymes for biofuels and biogas production by using metagenomic and genome editing approaches","volume":"11","author":"Banu","year":"2021","journal-title":"3 Biotech."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcab.2023.102928","article-title":"Bacterial biopolymers in tissue engineering and regenerative medicine; current applications and future perspective","volume":"54","author":"Bakhshandeh","year":"2023","journal-title":"Biocatal. Agric. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134535_bb0955","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0958-1669(02)00331-2","article-title":"Industrial microbial enzymes: their discovery by screening and use in large-scale production of useful chemicals in Japan","volume":"13","author":"Ogawa","year":"2002","journal-title":"Curr. Opin. Biotechnol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024053406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024053406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T21:06:11Z","timestamp":1782767171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024053406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":191,"alternative-id":["S0141813024053406"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134535","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive insight into exploring the potential of microbial enzymes in cancer therapy: Progress, challenges, and opportunities: A review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134535"}}